Home
/
Camp4 Therapeutics Corp
/
Financials
/
Quarterly
Camp4 Therapeutics Corp — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Camp4 Therapeutics Corp filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2024
Sep 30, 2023
$350.0K
Nov 21, 2024
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$795.0K
Nov 6, 2025
Q2
2025
Jun 30, 2025
$1.50M
Aug 14, 2025
Q1
2025
Mar 31, 2025
$858.0K
May 13, 2025
Q3
2025
Sep 30, 2024
$0
Nov 6, 2025
Q2
2025
Jun 30, 2024
$0
Aug 14, 2025
Q1
2025
Mar 31, 2024
$0
May 13, 2025
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($15.10M)
Nov 6, 2025
Q2
2025
Jun 30, 2025
($12.59M)
Aug 14, 2025
Q3
2025
Jun 30, 2025
($12.59M)
Nov 6, 2025
Q3
2025
Mar 31, 2025
($12.43M)
Nov 6, 2025
Q1
2025
Mar 31, 2025
($12.43M)
May 13, 2025
Q2
2025
Mar 31, 2025
($12.43M)
Aug 14, 2025
Q3
2025
Sep 30, 2024
($13.48M)
Nov 6, 2025
Q2
2025
Jun 30, 2024
($12.58M)
Aug 14, 2025
Q3
2025
Jun 30, 2024
($12.57M)
Nov 6, 2025
Q1
2025
Mar 31, 2024
($12.45M)
May 13, 2025
Q2
2025
Mar 31, 2024
($12.45M)
Aug 14, 2025
Q3
2025
Mar 31, 2024
($12.46M)
Nov 6, 2025
Q3
2024
Sep 30, 2023
($11.70M)
Nov 21, 2024
Q3
2024
Jun 30, 2023
($12.10M)
Nov 21, 2024
Q3
2024
Mar 31, 2023
($12.51M)
Nov 21, 2024
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($13.65M)
Nov 6, 2025
Q2
2025
Jun 30, 2025
($13.03M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($13.10M)
May 13, 2025
Q3
2025
Sep 30, 2024
($13.52M)
Nov 6, 2025
Q2
2025
Jun 30, 2024
($12.66M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($12.88M)
May 13, 2025
Q3
2024
Sep 30, 2023
($12.34M)
Nov 21, 2024